July 6, 2021 – Sheng Ye Capital Limited (“SY Capital” or the “Company”, HKEx: 6069), a leading supply chain fintech platform, today announced that it has entered into a strategic partnership with Lianren Digital Health Technology Co., Ltd. (“Lianren Digital Health”). The two companies will collaborate to promote big data applications in areas including digitalization of the medical sector, data analytics, Internet of Things (“IoT”) technology and supply chain digital financing solutions. The collaboration will also explore innovative models to integrate “digital health + digital supply chain” services. The partnership will leverage SY Capital’s strengths in supply chain technologies and Lianren Digital Health’s extensive medical data assets to empower medical suppliers with flexible digital supply chain management and financing solutions, enhancing the supply chain efficiency in the healthcare sector.

Pharmaceuticals has been one of SY Capital’s focus sectors where it has accumulated a wealth of real-time transaction data over the last seven years. Building on its in-depth insight into a number of use case scenarios of drug distribution and strong digital risk control capability, SY Capital effectively addresses the financing needs of pharmaceutical companies. As a leading supply chain fintech platform, SY Capital has established strategic cooperation with various blue-chip core enterprises and developed close connections with a range of players across the supply chain ecosystem. By providing hospital supply, processing and distribution ("SPD") services and Software-as-a-Service ("SaaS") solutions, SY Capital is able to connect to the transaction data systems of partnering core enterprises. This data access allows SY Capital to provide flexible supply chain financing services through online loan approval processes, automated data processing and robust big data-powered risk control.

Lianren Digital Health, a digital healthcare corporation jointly established by Chinese state-owned enterprises (“SOEs”) including China Mobile Capital Holding Co., Ltd., China Pacific Life Insurance Co., Ltd., Jinan International Medical Center Industry Development Co., Ltd., and Shanghai Pudong Venture Capital Fund, and regional government. Invested by SOEs and with government capital, Lianren Digital Health’s market-driven operating approach is aligned to follow the nation’s “new infrastructure” and “market-based allocation of production factors” initiatives. Lianren Digital Health will leverage its strong medical data integration and R&D capabilities to provide digital medical solutions, technology services, and build a closed-loop healthcare data ecosystem, with an aim of facilitating China’s medical and healthcare system reform – encompassing medical services, healthcare insurance and pharmaceutical distribution. Lianren Digital Health cooperates extensively with a number of medical institutions and businesses, working together to build a medical data ecosystem, promote new models of medical services and support the overall development of healthcare services in China.

Going forward, SY Capital will continue to pursue its development strategy to explore strategic opportunities in SaaS, digital technology, IoT, and supply chain platforms. The strategic partnership with Lianren Digital Health will help SY Capital to better connect with the medical data ecosystem and facilitate the digital transformation of inclusive financing.